131 related articles for article (PubMed ID: 25874302)
1. [The alternative view on diagnostic of hyperlipoproteinemia, cholesterol lipoproteins of low density and effect of statins: a lecture].
Tupoleva TA; Tikhomirov DS; Grumbkova LO; Ignatova EN; Romanova TIu; Filatov FP; Garanzha TA
Klin Lab Diagn; 2015 Jan; 60(1):27-38. PubMed ID: 25874302
[TBL] [Abstract][Full Text] [Related]
2. [THE SPIRIT CHOLESTEROL, BIOLOGICA L ROLE AT STAGES OF PHYLOGENESIS, MECHANISMS OF INHIBITION OF SYNTHESIS OF STEROL BY STATINS, FACTORS OF PHARMACOGENOMICS AND DIAGNOSTIC SIGNIFICANCE OF CHOLESTEROL OF LIPOPROTEINS OF LOW DENSITY].
Titov VN; Kotlovskii MY; Pokrovskii AA; Kotlovskaia OS; Osedko AV; Titova NM; Kotlovskii YV; Digaii AM
Klin Lab Diagn; 2015 Apr; 60(4):4-13. PubMed ID: 26189285
[TBL] [Abstract][Full Text] [Related]
3. [THE EFFECT OF SATINS: ACTIVATION OF LIPOLYSIS AND ABSORPTION BY INSULIN-DEPENDED CELLS LIPOPROTEINS OF VERY LOW DENSITY, INCREASING OF BIO-AVAILABILITY OF POLYENOIC FATTY ACIDS AND DECREASING OF CHOLESTEROL OF LIPOPROTEINS OF LOW DENSITY].
Titov VN; Malyshev PP; Amelyushkina VA; Aripovsky AV; Smirnov GP; Polevaya TY; Kabo SI; Kukhartchuk VV
Klin Lab Diagn; 2015 Oct; 60(10):4-12. PubMed ID: 26841664
[TBL] [Abstract][Full Text] [Related]
4. [The becoming of reactions of lipolysis in phylogenesis. The palmitic and oleic triglycerides as substrates. Insulin, condition of normolipemia and formation of hyper lipoproteinemia type IIb, IV and V].
Titov VN; Rozhkova TA; Aripovsky AV; Amelyushkina VA; Karganov MY
Klin Lab Diagn; 2018; 63(1):4-15. PubMed ID: 30550084
[TBL] [Abstract][Full Text] [Related]
5. [THE BECOMING IN PHYLOGENESIS OF TRANSFER IN INTERCELLULAR MEDIUM AND ACTIVE ABSORPTION OF POLYENOIC FATTY ACIDS BY CELLS SEQUENTIALLY OF HIGH DENSITY LIPOPROTEINS, LOW DENSITY LIPOPROTEINS AND HIGH DENSITY APOE-LIPOPROTEINS].
Titov VN
Klin Lab Diagn; 2015 Jun; 60(6):4-14. PubMed ID: 26466444
[TBL] [Abstract][Full Text] [Related]
6. [The positional isomers of palmitic and oleic triglycerides, lipolysis, conformation of apoB-100, formation of apoE/B-100 ligand and absorption of lipoproteins of very low density by insulin-dependent cells under action of statins.].
Titov VN; Yakimenko AV; Kotlovskii MY; Aripovskii AV; Smirnov GP; Malishev PP
Klin Lab Diagn; 2016; 61(11):736-743. PubMed ID: 31532941
[TBL] [Abstract][Full Text] [Related]
7. [The clinical biochemistry of hypo-lipedemic therapy and mechanisms of action of statins: the fatty acids, statins and diabetes mellitus].
Titov VN
Klin Lab Diagn; 2014 Feb; (2):4-15. PubMed ID: 25069226
[TBL] [Abstract][Full Text] [Related]
8. [Variability of the hypolipidemic action of simvastatin and fluvastatin in patients with primary hyperlipoproteinemia].
Tvorogova MG; Susekov AV; Semenova OA; Kukharchuk VV; Titov VN
Ter Arkh; 1998; 70(12):8-13. PubMed ID: 10067240
[TBL] [Abstract][Full Text] [Related]
9. [THE ETIOLOGY AND PATHOGENESIS OF SUCCESSIVE MAKING TEST ON HYPERTRIGLYCERIDEMIA, HYPERCHOLESTEROLEMIIA AND HYPOGLYCEMIA. THE COMMON CHARACTER OF ETIOLOGIC FACTORS OF METABOLIC PANDEMIC AND COMPENSATORY ROLE OF APOC-111].
Titov VN
Klin Lab Diagn; 2016 Jan; 61(1):4-12. PubMed ID: 27183722
[TBL] [Abstract][Full Text] [Related]
10. [THE LIPOLYSIS IN PHYLOGENETICALLY EARLY LIPOPROTEINS OF LOW DENSITY AND MORE LATER LIPOPROTEINS OF VERY LOW DENSITY: FUNCTION AND DIAGNOSTIC VALUE OF APOE AND APOC-III].
Rozhkova TA; Titov VN; Amelyushkina VA; Kaba SI; Kukhartchuk VV
Klin Lab Diagn; 2015 Dec; 60(12):4-14. PubMed ID: 27032246
[TBL] [Abstract][Full Text] [Related]
11. [How surplus of palmitic fatty acid in food initiates hypertriglyceridemia, increases cholesterol of low density lipoproteins, triggers atherosclerosis and develops atheromatosis.].
Rozhkova TA; Titov VN; Amelyushkina VA; Kuharchuk VV
Klin Lab Diagn; 2017; 62(6):330-338. PubMed ID: 31505108
[TBL] [Abstract][Full Text] [Related]
12. [The disturbance of unification of coupled biochemical reactions in synthesis of endogenous ω-9 oleic acid. The resistance to insulin, stearic triglycerides and pathogenesis of eruptive xanthomata].
Titov VN; Rozhkova TA; Samokhodskaya LM
Klin Lab Diagn; 2017 Feb; 62(2):68-77. PubMed ID: 30615382
[TBL] [Abstract][Full Text] [Related]
13. Role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors ("statins") in familial combined hyperlipidemia.
Schonfeld G; Aguilar-Salina C; Elias N
Am J Cardiol; 1998 Feb; 81(4A):43B-46B. PubMed ID: 9526813
[TBL] [Abstract][Full Text] [Related]
14. [The conformation of apoB-100 in phylogenetically and functionally different lipoproteins of low and very low density: algorithm of formation of phenotypes of hyper lipoproteinimia (a lecture)].
Titov VN; Amelyushkina VA; Rojkova TA
Klin Lab Diagn; 2014 Jan; (1):27-38. PubMed ID: 25069220
[TBL] [Abstract][Full Text] [Related]
15. Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models.
Krause BR; Newton RS
Atherosclerosis; 1995 Oct; 117(2):237-44. PubMed ID: 8801869
[TBL] [Abstract][Full Text] [Related]
16. [The carrier protein of cholesterol ethers: the physical chemical characteristics, functions, role in pathogenesis of atherosclerosis and grounds for inhibition (a lecture)].
Titov VN
Klin Lab Diagn; 2014 Aug; 59(8):29-36. PubMed ID: 25552051
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of hyperlipoproteinemia].
Drexel H; Follath F
Schweiz Rundsch Med Prax; 1993 Apr; 82(17):506-9. PubMed ID: 8493437
[TBL] [Abstract][Full Text] [Related]
18. [The atherosclerosis and atheromatosis as two etiologically different aphysiological processes at single pathogenesis. Atheromatosis and pathogenetic role of insulin.].
Rozhkova TA; Titov VN; Kaminnaya VI
Klin Lab Diagn; 2017; 62(12):708-718. PubMed ID: 30856301
[TBL] [Abstract][Full Text] [Related]
19. Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin.
Le NA; Innis-Whitehouse W; Li X; Bakker-Arkema R; Black D; Brown WV
Metabolism; 2000 Feb; 49(2):167-77. PubMed ID: 10690940
[TBL] [Abstract][Full Text] [Related]
20. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
